Dark Matter Therapeutics Inc. Inc
AI-driven phenotype-based discovery for more effective drugs in complex unmet medical conditions
Ce qui nous motive
Mission
Alter the Drug discovery paradigm from a target-centric one to an AI-driven phenotype based one.
Équipe
Membres de l'équipe
Steven Zimmer-co-founder and acting CEO Prof Lei Xie-Scientific Founder and acting CSO Yoyo Wu-AI Scientist-PhD student (April 2025)
Sur Foundersbase
Voir Dark Matter Therapeutics Inc. le profil complet de la société pour
- Identifier le potentiel de collaboration ou devenir membre de l'équipe
- En savoir plus sur "Dark Matter Therapeutics Inc. la vision et les offres de l'entreprise
- Se connecter et contacter "Dark Matter Therapeutics Inc. les fondateurs directement
Les gens ont aussi regardé
-
DeepNatures.com
wearable smart temp control module for human/humanoid/IDC
-
aponi.ai
Democratizing employment law with AI while capturing predictive signals for insurance carriers
-
Brooklyn Digital Media, Inc.
I am looking to produce projects encompassing audio, text and video.
-
Hemilion olfactory
Hemilion olfactory is filling the bridge between innovation and $64 billion industry ttm, cosmetics